"Regional Overview of Executive Summary Celiac Disease Testing Market by Size and Share

CAGR Value :  

• The global celiac disease testing market size was valued at USD 564.92 million in 2024 and is expected to reach USD 1.00 billion by 2032, at a CAGR of 7.20% during the forecast period

A study about the Celiac Disease Testing Market overview is performed by considering market drivers, market restraints, opportunities and challenges. Moreover, this Celiac Disease Testing Market report contains significant data, current market trends, market environment, technological innovation, upcoming technologies and the technical progress in the allied industry. This is the most relatable, exclusive, and commendable market research report formulated by focusing on definite business needs. The competitive analysis conducted in this report covers strategic profiling of key market players, their core competencies, and competitive landscape. To gain meaningful market insights and thrive in this competitive market place, this Celiac Disease Testing Market research report plays a key role.

This Celiac Disease Testing Market report also makes available major statistics on the market status of global and regional manufacturers and is a supportive source for companies and individuals interested in the Celiac Disease Testing Market industry. The careful efforts accompanied with integrated approaches gives an output of such excellent market research report that drives the decision making process of the business. This market report endows with a profound overview of product specification, technology, product type and production analysis by considering most important factors such as Revenue, Cost, Gross and Gross Margin. With this Celiac Disease Testing Market report businesses can successfully make decisions about business strategies to achieve maximum return on investment (ROI).

Learn how the Celiac Disease Testing Market is evolving—insights, trends, and opportunities await. Download report:
https://www.databridgemarketresearch.com/reports/global-celiac-disease-testing-market

Celiac Disease Testing Market Introduction

**Segments**

- By Test Type:
- Serology-based Tests
- Genetic Testing
- Endoscopic Biopsy
- By Sample:
- Blood
- Saliva
- By End-User:
- Hospitals
- Diagnostic Laboratories
- Academic and Research Institutes

Celiac disease testing market growth can be attributed to the rising prevalence of celiac disease globally. Serology-based tests segment dominates the market due to its high accuracy and efficiency in diagnosing celiac disease. Genetic testing is also gaining traction as it helps in identifying specific genetic markers associated with the disease. Endoscopic biopsy segment is crucial for confirming celiac disease diagnosis by assessing damage to the small intestine. Blood samples are the most commonly used sample type for celiac disease testing, owing to their convenience and reliability. Saliva samples are emerging as a non-invasive alternative for diagnosing celiac disease, especially in children. Hospitals account for the largest market share as they are equipped with advanced testing facilities and experienced healthcare professionals. Diagnostic laboratories play a key role in conducting specialized celiac disease tests, contributing significantly to market revenue. Academic and research institutes are focusing on developing innovative testing methods and raising awareness about celiac disease testing.

**Market Players**

- Quest Diagnostics
- Thermo Fisher Scientific
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- Hologic, Inc.
- Abbott
- Siemens Healthcare GmbH
- Biomerica Inc.
- Takeda Pharmaceutical Company Limited
- GIANTMED
- Cell Science Systems
- Mayo Foundation for Medical Education and Research

Key market players such as Quest Diagnostics, Thermo Fisher Scientific, and Bio-Rad Laboratories, Inc. are investing in research and development activities to introduce advanced celiac disease testing solutions. F. Hoffmann-La Roche Ltd and Hologic, Inc. are focusing on strategic collaborations and partnerships to expand their market presence. Abbott and Siemens Healthcare GmbH are expanding their product portfolios to cater to the increasing demand for celiac disease testing. Biomerica Inc. and Takeda Pharmaceutical Company Limited are emphasizing geographic expansion to tap into new market opportunities. GIANTMED, Cell Science Systems, and Mayo Foundation for Medical Education and Research are actively involved in clinical trials and studies to enhance celiac disease testing accuracy and efficiency.

The global celiac disease testing market is witnessing significant growth driven by the increasing prevalence of celiac disease worldwide. This rise in prevalence is fueled by factors such as changing dietary patterns, increased awareness about the disease, and advancements in diagnostic technologies. As a result, the demand for accurate and efficient celiac disease testing methods is on the rise, leading to a surge in market growth. The market is segmented based on test types, samples, and end-users to cater to the diverse needs of healthcare professionals and patients seeking celiac disease diagnosis. The serology-based tests segment remains dominant in the market owing to its high accuracy and effectiveness in diagnosing celiac disease. Genetic testing is also gaining prominence as it helps in identifying specific genetic markers associated with the disease, aiding in personalized treatment strategies. The endoscopic biopsy segment plays a crucial role in confirming celiac disease diagnosis by assessing damage to the small intestine, further highlighting the importance of comprehensive testing approaches.

In terms of sample types, blood samples continue to be the preferred choice for celiac disease testing due to their convenience and reliability. However, saliva samples are emerging as a non-invasive alternative, particularly beneficial in pediatric populations. This shift towards non-invasive testing methods is expected to drive market growth by improving patient compliance and overall testing experience. In terms of end-users, hospitals hold the largest share in the market, supported by their advanced testing facilities and skilled healthcare professionals capable of conducting complex celiac disease tests. Diagnostic laboratories also play a critical role in offering specialized testing services, contributing significantly to market revenue. Academic and research institutes are at the forefront of developing innovative testing methods and raising awareness about celiac disease testing, further propelling market expansion.

Key market players such as Quest Diagnostics, Thermo Fisher Scientific, and Bio-Rad Laboratories, Inc. are at the forefront of the celiac disease testing market, focusing on research and development initiatives to introduce cutting-edge testing solutions. Collaborations and partnerships are key strategies employed by companies like F. Hoffmann-La Roche Ltd and Hologic, Inc., aimed at expanding their market presence and enhancing product offerings. Other players such as Abbott and Siemens Healthcare GmbH are expanding their product portfolios to meet the growing demand for celiac disease testing solutions globally. Geographic expansion is a key focus for companies like Biomerica Inc. and Takeda Pharmaceutical Company Limited, as they seek to tap into new market opportunities and strengthen their market position. Additionally, active involvement in clinical trials and studies by companies like GIANTMED, Cell Science Systems, and Mayo Foundation for Medical Education and Research is driving innovation and advancing celiac disease testing accuracy and efficiency.The global celiac disease testing market is poised for significant growth in the coming years due to several key drivers. One major factor contributing to the market expansion is the increasing prevalence of celiac disease on a global scale. Changing dietary patterns, heightened awareness about the condition, and advancements in diagnostic technologies are further propelling this growth. As a result, there is a growing demand for accurate and efficient testing methods to diagnose celiac disease effectively. The market segmentation based on test types, samples, and end-users allows for customized solutions catering to the diverse requirements of healthcare professionals and patients seeking celiac disease diagnosis.

In terms of test types, the dominance of serology-based tests in the market can be attributed to their high accuracy and effectiveness in diagnosing celiac disease. Genetic testing is also gaining traction for its ability to identify specific genetic markers linked to the disease, facilitating personalized treatment approaches. The endoscopic biopsy segment plays a critical role in confirming celiac disease diagnosis by evaluating damage to the small intestine, underscoring the importance of comprehensive testing strategies. The preference for blood samples in celiac disease testing is primarily due to their convenience and reliability. However, the emergence of saliva samples as a non-invasive alternative, especially beneficial for pediatric populations, is expected to drive market growth by enhancing patient compliance and overall testing experience.

Among end-users, hospitals hold a significant market share supported by their advanced testing facilities and skilled healthcare professionals capable of conducting intricate celiac disease tests. Diagnostic laboratories are instrumental in providing specialized testing services, thus making a substantial contribution to market revenue. Academic and research institutes are actively engaged in developing innovative testing methods and raising awareness about celiac disease testing, further fueling market expansion.

Key market players such as Quest Diagnostics, Thermo Fisher Scientific, and Bio-Rad Laboratories, Inc. are intensifying their focus on research and development endeavors to introduce state-of-the-art testing solutions. Strategic collaborations and partnerships are key strategies employed by companies like F. Hoffmann-La Roche Ltd and Hologic, Inc., aimed at expanding market presence and enhancing product offerings. Expansion of product portfolios to meet the growing demand for celiac disease testing solutions is a priority for companies like Abbott and Siemens Healthcare GmbH. Geographic expansion strategies pursued by entities such as Biomerica Inc. and Takeda Pharmaceutical Company Limited are geared towards tapping into new market opportunities and bolstering market positioning. The active involvement in clinical trials and studies by players like GIANTMED, Cell Science Systems, and Mayo Foundation for Medical Education and Research is driving innovation, thereby advancing celiac disease testing accuracy and efficiency.

Gain insights into the firm’s market contribution
https://www.databridgemarketresearch.com/reports/global-celiac-disease-testing-market/companies

Celiac Disease Testing Market – Analyst-Ready Question Batches

• What is the global market size for the Celiac Disease Testing sector currently?
• What is the expected growth trajectory for the Celiac Disease Testing Market?
• What are the segment highlights provided in the Celiac Disease Testing Market report?
• Which enterprises are leading the Celiac Disease Testing Market space?
• Which nations have detailed data in the Celiac Disease Testing report?
• What major brands are identified in the Celiac Disease Testing Market?

Browse More Reports:

North America Plant Based Protein Market
Global Radiotheranostics Market
Europe Small Molecule Sterile Injectable Drugs Market
Global Tachycardia Drugs Market
Global Terminal Automation Market
Global Pipeline Transportation Market
North America Polyimide Films Market
Global Propylene Glycol Market
Global Electric Heat Tracing (EHT) Market
Global Digital Assistant Market
Europe Molded Plastics Market
Global Individual Quick Freezing (IQF) Meat and Poultry Market
Global Internet of Things (IoT) Node and Gateway Market
Global Idiopathic Intracranial Hypertension Treatment Market
Global Blast Chillers Market
North America Testing, Inspection, and Certification (TIC) Market for Building and Construction – Industry Trends and Forecast to 2028
Middle East and Africa Food Bags Market
Latin America Rotomolding Market
Global Automotive Energy Absorption (EA) Pads Market
Europe Methylene Diphenyl Diisocyanate (MDI) Toluene Diisocyanate (TDI) and Polyurethane Market
Global Doors Market
Global Insulation Coating Materials Market
Europe Acute Lymphocytic/Lymphoblastic Leukemia (ALL) Diagnostics Market
Global Cercarial Dermatitis Market
Global X-Ray Fluorescence Analyser Market
Middle East and Africa IoT Node and Gateway Market
Global Blood Meal Market
Global Two Part Adhesive Market
Middle East and Africa Potato Processing Market
Europe Indium Market
North America Probe Card Market

Europe Molecular Diagnostics Market

About Data Bridge Market Research:

An absolute way to forecast what the future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Email:- corporatesales@databridgemarketresearch.com

 "